Summary
- Splice variants
- Transcript comparison
- Gene alleles
Sequence
- Secondary Structure
Comparative Genomics
Ontologies
- GO: Biological process
- GO: Molecular function
- GO: Cellular component
Phenotypes
Genetic Variation
Gene expression
Pathway
Molecular interactions
Regulation
External references
Supporting evidence
ID History
- Gene history

Configure this page

Share this page

Bookmark this page

.

Gene: LEPROT ENSBTAG00000005909

.

Description

leptin receptor overlapping transcript [Source:VGNC Symbol;Acc:VGNC:30844]

Location

Primary_assembly 3: 79,914,162-79,925,688 reverse strand.

ARS-UCD1.3:CM008170.2

About this gene

This gene has 4 transcripts (splice variants), 206 orthologues and 1 paralogue.

Transcripts

Show transcript tableHide transcript table

Transcript ID	Name	bp	Protein	Translation ID	Biotype	UniProt Match	Flags
ENSBTAT00000079709.2	LEPROT-203	2510	236aa	ENSBTAP00000063579.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A3Q1M1I1	A single transcript chosen for a gene which is the most conserved, most highly expressed, has the longest coding sequence and is represented in other key resources, such as NCBI and UniProt. This is defined in detail on http://www.ensembl.org/info/genome/genebuild/canonical.htmlEnsembl Canonical,
ENSBTAT00000103348.1	LEPROT-201	2041	146aa	ENSBTAP00000094107.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	-	-
ENSBTAT00000007762.3	LEPROT-202	2025	131aa	ENSBTAP00000007762.3	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A452DIS0	APPRIS P1: Transcript(s) expected to code for the main functional isoform based solely on the core modules in the APPRIS. APPRIS is a system to annotate alternatively spliced transcripts based on a range of computational methods to identify the most functionally important transcript(s) of a gene. APPRIS P1,
ENSBTAT00000087229.2	LEPROT-204	455	142aa	ENSBTAP00000061935.2	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A3Q1M1K8	-

.

Summary

.

.